Forbes William P — SEC Form 4 filings
SEC reporting owner CIK 1314760. 26 Form 4 filings on record with FilingPulse; latest filed 2026-08-03.
Transaction summary — filings shown
Covers all 26 filings on record, filed 2024-01-19 to 2026-08-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 83.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Development Officer | 22 | — | — | 51 |
| Beyond Air, Inc. (XAIR) | Director | 4 | — | — | 32 |
Form 4 filings — Forbes William P
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 11,769 · Tax withholding (F): 3,348 @ $0.50 · Option exercise (M): 11,694 · Tax withholding (F): 3,326 @ $0.50 · Option exercise (M): 11,769 (derivative) @ $0 · Option exercise (M): 11,694 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Tax withholding (F): 1,101 @ $0.47 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 12,500 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 11,694 · Option exercise (M): 11,770 · Option exercise (M): 11,694 (derivative) @ $0 · Option exercise (M): 11,770 (derivative) @ $0 | EDGAR |
| 2026-04-21 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 11,695 · Option exercise (M): 11,695 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 188,315 (derivative) @ $0 · Grant/award (A): 188,314 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,875 · Option exercise (M): 3,875 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | Beyond Air, Inc. (XAIR) | Disposition to issuer (D): 1,250 (derivative) · Grant/award (A): 1,250 (derivative) · Disposition to issuer (D): 400 (derivative) · Grant/award (A): 400 (derivative) · Disposition to issuer (D): 1,250 (derivative) · Grant/award (A): 1,250 (derivative) · +10 more | EDGAR |
| 2025-11-04 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 11,694 · Option exercise (M): 11,694 (derivative) @ $0 | EDGAR |
| 2025-10-21 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 11,695 · Option exercise (M): 11,695 (derivative) @ $0 | EDGAR |
| 2025-07-22 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 12,500 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 11,694 · Option exercise (M): 11,694 (derivative) @ $0 | EDGAR |
| 2025-04-22 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,875 · Option exercise (M): 3,875 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Beyond Air, Inc. (XAIR) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 374,220 (derivative) @ $0 · Grant/award (A): 187,110 (derivative) @ $0 | EDGAR |
| 2025-01-22 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2024-11-26 | 4 | Beyond Air, Inc. (XAIR) | Disposition to issuer (D): 25,000 (derivative) · Grant/award (A): 25,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Grant/award (A): 8,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Grant/award (A): 25,000 (derivative) · +8 more | EDGAR |
| 2024-10-21 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2024-07-22 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,875 · Option exercise (M): 3,875 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 12,500 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2024-04-19 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2024-03-21 | 4 | Beyond Air, Inc. (XAIR) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 371,935 (derivative) @ $0 · Grant/award (A): 61,989 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1314760 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →